Epstein-Peterson, Z., Ganesan, N., Poh, C., Advani, R., Aypar, U., Bowler, B., Casper, E., Chang, T., Dogan, A., Eren, O. C., Feldman, T., Galasso, N., Gautam, V., Ghione, P., Gill, S., Hannigan, K., Isenberg, J., Iyer, S., Ksanznak, K., Lytle, A., Moreira, J., Moskowitz, A., Nair, R., Oh, T., Orlando, E., Ruan, J., Savage, K., Slack, G., Stuver, R., Xu, J., Yeung, A., Zain, J., Zhang, Y., Horwitz, S. (2025). Impact of DUSP22 and TP63 rearrangements in patients with ALK-negative ALCL treated with frontline BV-CH(E)P. Blood. https://doi.org/10.1182/blood-2025-5410